NCT00957762

Brief Summary

The purpose of this research is to evaluate different methods of measuring body composition (amount of fat, muscle, bone, and water in your body) and to determine relationships between body composition and other medical problems associated with spinal cord injury (SCI).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
170

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

August 5, 2009

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 12, 2009

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

August 12, 2009

Status Verified

August 1, 2009

Enrollment Period

3.1 years

First QC Date

August 5, 2009

Last Update Submit

August 11, 2009

Conditions

Keywords

Body CompositionGlucose ToleranceInsulin SensitivityMetabolic Syndrome

Outcome Measures

Primary Outcomes (1)

  • To compare different methods of body composition analyses with the gold standard 4-compartment monitoring to determine accuracy and validity of those alternative, but less labor-intensive techniques.

    3 years

Secondary Outcomes (3)

  • To assess the relationship between % body fat, visceral fat, and markers of the metabolic syndrome, including Plasminogen Activator Inhibitor-1 (PAI-1), Thrombin-Activatable Fibrinolysis Inhibitor (TAFI), and high-sensitivity C-Reactive Protein (hsCRP)

    3 years

  • To develop body composition regression equations that can be easily utilized in a clinical setting to estimate risk for the metabolic syndrome in persons with SCI.

    3 years

  • To cross-validate the derived regression equations against the gold standard 4-compartment model in an independent group of persons with SCI.

    3 years

Study Arms (1)

Body Composition

120 subjects will help create the regression models. The remaining 50 subjects will be recruited to determine if the equations work for the population.

Other: Body composition

Interventions

Day 1 testing will incorporate underwater weighing, Bod Pod, DXA, BIA and anthropometrics. Day 2 will include RMR, MRI, and testing at GCRC

Also known as: Spinal Cord Injury, Percentage body fat
Body Composition

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals with a spinal cord injury of C5-L2 motor complete (AIS A\&B only).

You may qualify if:

  • Criteria for participation will include men and women within the age range of 18-65 years old with C5-L2 Motor-Complete (ASIA A\&B)
  • SCI of duration greater than 12 months to ensure a homogenous sample.

You may not qualify if:

  • Persons with uncompensated hypothyroidism, and/or renal disease will be excluded from the study.
  • Additionally, individuals with uncontrolled autonomic dysreflexia, recent (within 3 months) deep vein thrombosis
  • Pressure ulcers \> Grade II will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hunter Holmes McGuire Spinal Cord Injury Research Lab

Richmond, Virginia, 23249, United States

RECRUITING

MeSH Terms

Conditions

Diabetes MellitusQuadriplegiaParaplegiaSpinal Cord InjuriesInsulin ResistanceMetabolic Syndrome

Interventions

Body CompositionCreb3l2 protein, rat

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal Cord DiseasesCentral Nervous System DiseasesTrauma, Nervous SystemWounds and InjuriesHyperinsulinism

Intervention Hierarchy (Ancestors)

Biochemical PhenomenaChemical PhenomenaMetabolismBody ConstitutionPhysiological Phenomena

Study Officials

  • David R Gater, MD, PhD

    Hunter Holmes McGuire VAMC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joshua Miller, MS

CONTACT

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
FED

Study Record Dates

First Submitted

August 5, 2009

First Posted

August 12, 2009

Study Start

August 1, 2009

Primary Completion

September 1, 2012

Study Completion

October 1, 2012

Last Updated

August 12, 2009

Record last verified: 2009-08

Locations